title: β₂-Agonist therapy may contribute to the air pollution and IL-6-associated risk of developing severe asthma with dual-positive TH2/TH17 cells.
authors.affiliation: Division of Allergy and Immunology, Northwestern University, Chicago, Ill.
authors.forename: Sergio E
authors.initials: SE
authors.lastname: Chiarella
authors.affiliation: Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, Ill.
authors.forename: G R Scott
authors.initials: GR
authors.lastname: Budinger
authors.affiliation: Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Ill. Electronic address: gmutlu@uchicago.edu.
authors.forename: Gökhan M
authors.initials: GM
authors.lastname: Mutlu
mesh_terms: D001249:Asthma / Q000276:immunology*; D018893:Bronchoalveolar Lavage; D005260:Female; D006801:Humans; D008297:Male; D058504:Th17 Cells / Q000276:immunology*; D018418:Th2 Cells / Q000276:immunology*